fluoxetine has been researched along with Atrial Septal Defect in 2 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Christodoulos, IN | 1 |
Chyou, TY | 1 |
Nishtala, PS | 1 |
Grover, S | 1 |
Agarwal, M | 1 |
Hegde, A | 1 |
Malhotra, N | 1 |
Somaiya, M | 1 |
Ghormode, D | 1 |
2 other studies available for fluoxetine and Atrial Septal Defect
Article | Year |
---|---|
Safety of fluoxetine use in children and adolescents: a disproportionality analysis of the Food and Drug Administration Adverse Event Reporting System (FAERS) database.
Topics: Adolescent; Adverse Drug Reaction Reporting Systems; Antidepressive Agents, Second-Generation; Anxie | 2020 |
Electroconvulsive therapy in the presence of atrial septal defect: a case report.
Topics: Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepines; Combined Modality T | 2012 |